6
Views
11
CrossRef citations to date
0
Altmetric
Original Article

The effect of immunization route and sequence of stimulation on the induction of IgA antibodies in tears

, , &
Pages 861-866 | Received 31 Jan 1984, Accepted 13 Mar 1984, Published online: 02 Jul 2009
 

Abstract

The capacity of ocular/topical (OT) or gastrointestinal (Gl) immunization routes alone or sequentially to elicit and maintain tear IgA antibody responses was assessed in the rat model. Seven days after each biweekly immunization with dinitrophenylated type-III pneumococcal vaccine, the IgA antibody levels in serum, saliva and tears were measured. All groups generally lacked serum IgA responses and eventually possessed similar salivary response frequencies with OT, OT/GI and GI groups showing a tendency for increased salivary IgA antibody levels. Tear IgA antibody responses in all groups were comparable after the third immunization. Subsequently the OT group displayed a gradual reduction in response frequency with a significant drop in IgA levels after the sixth immunization. The OT/GI group maintained tear IgA response frequencies while displaying a significant increase in tear IgA antibody levels; the GI and GI/OT groups maintained tear IgA antibody responses. These data demonstrate that the immunization route and sequence of stimulation have a marked impact on the expression of IgA anti-DNP antibodies in tears.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.